LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$9.10
+3.76% today
Updated 2026-04-30
Market cap
$78.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.70
Dividend yield
—
52W range
$2 – $14
Volume
0.1M
LeonaBio, Inc. (LONA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | $2.00M | $479000.00 | — | — | — | $68.09M |
| Gross profit | — | — | $-2.00M | $-479000.00 | — | — | — | $-68.09M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $3.59M | $3.79M | $13.29M | $42.79M | $61.46M | $93.79M | $70.68M | $17.50M |
| SG&A | $1.42M | $1.66M | $6.71M | $21.23M | $32.55M | $33.30M | $26.09M | $16.68M |
| Operating income | $-5.01M | $-5.45M | $-20.00M | $-64.02M | $-104.02M | $-125.47M | $-100.90M | $-102.27M |
| Operating margin | — | — | — | — | — | — | — | — |
| EBITDA | $-79000.00 | $-4.81M | $-19.59M | $-54.37M | $-88.01M | $-125.97M | $-95.81M | $-102.27M |
| EBITDA margin | — | — | — | — | — | — | — | — |
| EBIT | $-5.09M | $-4.82M | $-19.59M | $-54.85M | $-88.86M | $-126.94M | $-96.78M | — |
| Interest expense | $9000.00 | $346000.00 | $367000.00 | $3000.00 | $24.32M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.10M | $-5.16M | $-19.95M | $-54.85M | $-95.64M | $-117.67M | $-96.94M | $-105.61M |
| Net income growth (YoY) | — | -1.3% | -286.6% | -174.9% | -74.4% | -23.0% | +17.6% | -8.9% |
| Profit margin | — | — | — | — | — | — | — | — |